We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CHMP Recommends Six New Drugs, Including Novel Triple-Negative Breast Cancer Therapy
CHMP Recommends Six New Drugs, Including Novel Triple-Negative Breast Cancer Therapy
The European Medicines Agency’s (EMA) expert panel on human medicines has recommended approval for Gilead Sciences’ novel therapy for an aggressive form of breast cancer and for five other drugs.